Patents by Inventor Fanny Mochel

Fanny Mochel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Urinary Triaosylceramide (GB3) as a Marker of Cardiac Disease
    Publication number: 20110172271
    Abstract: The present invention describes a method for determination of urinary globotriaosylceramide (Gb3) levels in non-Fabry disease cardiac patients. Determination of Gb3 levels provides a screening method for determining cardiac risk and may offer an alternative therapeutic option for cardiac disease management or cardiac disease risk mitigation by lowering Gb3 levels by the use of pharmacological chaperones or other agents.
    Type: Application
    Filed: November 17, 2010
    Publication date: July 14, 2011
    Applicant: Baylor Research Institute
    Inventors: Raphael Schiffmann, Fanny Mochel, Lawrence Sweetman, Sabrina Forni
  • Anaplerotic Therapy of Huntington Disease and Other Polyglutamine Diseases
    Publication number: 20100063147
    Abstract: The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof.
    Type: Application
    Filed: December 3, 2007
    Publication date: March 11, 2010
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Alexandra Durr, Fanny Mochel